Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.11909/j.issn.1671-5411.2016.12.008 http://scihub22266oqcxt.onion/10.11909/j.issn.1671-5411.2016.12.008 C5351831!5351831!28321243     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28321243&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28321243.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Geriatr+Cardiol 2016 ; 13 (12): 992-7 Nephropedia Template TP {{tp|p=28321243|t=2016. Cardiac drug therapy?considerations in the elderly |pdf=|usr=}}{{28321243}} gab.com Text Cardiac drug therapy considerations in the elderly JO: J Geriatr Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=28321243 #FOAvip Elderly individuals constitute a majority of patients encountered in current cardiovascular clinical practice. Management of these patients is a clinical challenge owing to a multitude of factors. Although medications such as statins have been shown to reduce cardiovascular mortality in the general population, evidence supporting the use of these drugs in patients greater than 75 years of age is sparse. Furthermore, aging associated changes in organ function and associated comorbidities influence the pharmacokinetics of multiple medications and can potentiate drug toxicity. In this article, we review the evidence behind the use of common cardiovascular medications in elderly patients and discuss pertinent clinical challenges. Twit Text FOAVip Cardiac drug therapy considerations in the elderly ????J Geriatr Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=28321243 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28321243 #FOAvip English Wikipedia <ref>{{Cite pmid|28321243}}</ref> Cardiac drug therapy?considerations in the elderly #MMPMID28321243 Ayan M; Pothineni NV; Siraj A; Mehta JL J Geriatr Cardiol 2016[Dec]; 13 (12): 992-7 PMID28321243show ga Elderly individuals constitute a majority of patients encountered in current cardiovascular clinical practice. Management of these patients is a clinical challenge owing to a multitude of factors. Although medications such as statins have been shown to reduce cardiovascular mortality in the general population, evidence supporting the use of these drugs in patients greater than 75 years of age is sparse. Furthermore, aging associated changes in organ function and associated comorbidities influence the pharmacokinetics of multiple medications and can potentiate drug toxicity. In this article, we review the evidence behind the use of common cardiovascular medications in elderly patients and discuss pertinent clinical challenges. äCardiac drug therapy?considerations in the elderly (epmc).pdf DeepDyve Pubget Overpricing